Harbor Disruptive Innovation ETF (INNO) News
Track canonical SquawkNews coverage tagged to INNO, Harbor Disruptive Innovation ETF. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
INNO revenue down 25% YoY; gross margin at 90.8%
INNO reported revenue down 25% year-over-year. Gross margin stayed strong at 90.8%.
EQUITY | Aug 31, 2026, 08:23 PM UTC
M
Innocan Pharma posts Q2 FY2026 revenue of US$5.25M (CAD 7.3M)
Innocan Pharma reported second quarter fiscal year 2026 revenue of US$5.25M (CAD 7.3M).
EQUITY | Aug 31, 2026, 08:01 PM UTC